A pharmaceutical composition for treating malignant pleural effusion, its preparation method and application

Abstract

The invention provides a medicine composite for treating malignant pleural effusion. The medicine composite is prepared with, by weight, 2-18 parts of American ginseng, 4-30 parts of pseudo-ginseng, 2-18 parts of pepperweed seeds, 3-21 parts of pyrrosia lingua, 2-8 parts of seeds of zanthoxylom bungeanum maxim, 10-50 parts of cynanchum paniculatum, 5-25 parts of snake gourd fruits, 10-50 parts of raw radix astragalis, 2-18 parts of rhizoma alismatis, 3-21 parts of rhizoma atractylodis macrocephalae and 2-12 parts of Chinese dates. All ingredients cooperate with one another, the medicine composite is placed in water for dissolution before drinking and is effective in warming the Yang, smoothing the Qi, communicating the Yang and the Qi, excreting the dampness and tonifying the spleen, and all medicine cooperate to achieve that the Yang is warmed and the effusion is relieved. Clinical tests prove that the medicine composite is capable of effectively treating the malignant pleural effusion.

Description

Technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating malignant pleural effusion and a preparation method thereof. Background technique [0002] Malignant pleural effusion refers to pleural effusion caused by lung cancer or other malignant tumors involving the pleura or primary tumors of the pleura. Except for primary brain tumors and extremity tumors, almost all malignant tumors can cause malignant pleural effusion. Among them, lung cancer is the most common, breast cancer ranks second, and lymphoma again, about 5%-10% of malignant pleural effusions The fluid could not find the primary tumor. [0003] Malignant pleural effusion is one of the common complications of advanced tumors, most of which are the result of disease progression or recurrence. It can also be the first clinical manifestation of tumor patients, which seriously affects the survival time and quality of life of patients. A large amo...

AI Technical Summary

Problems solved by technology

In the patent document 201010284152.0, the power of warming the yang is also insufficient, and the focus is on the regression of pleural effusion and the reduction of adverse reactions. The prescriptions are scattered, there are too many drugs, and the main line is unclear, so it is difficult to play an effective therapeutic role.

The flaws in the prescription of the above-mentioned patented technology determine that it is difficult to produce good clinical effects